BioSpace News Archive

Eon , a Denver -based healthtech leader, recently launched Centralized Management , the only market available patient management service to fully manage every aspect of a lung cancer screening

Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced a first-of-its-kind study to improve outcomes for patients diagnosed with a rare disease known as Tuberous Sclerosis Complex (TSC). Surrogen, a subsidiary of Recombinetics Inc., is focused on d

Trinity Life Sciences, a leader in global life sciences solutions, introduces a new field force impact benchmarking service called Trinity Stakeholder Voice

Limitless Venture Group, Inc. announced it has signed a term sheet to acquire a majority interest in an unnamed Managing General Underwriter.

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of primary and metastatic cancers, today announced that it will host a conference call on November 11, 2020 at 8:30 AM Eastern Time to discuss results for its third quarter ended September 30, 2020. Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Date: November

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that the company will release its third quarter 2020 financial results after the market closes on Monday, November 16, 2020. Management will host a conference call with a slide presentation at 5:00 p.m. ET (2:00 p.m. PT) on the same day to provide an update on t

Urges Shareholders to Sign and Return Ziopharm’s GREEN Consent Revocation Card Emphasizes that Substantial Board Refr eshment is Already in Process Reiterates Commitment to Implementing Strategy and Delivering Significant Value to S hareholders Questions WaterMill’s Attempt to Seize Outsize d Influence over Board

TraceLink Inc., the leading digital platform company for the life sciences industry, announced the first round of grant recipients in response to the Company’s commitment to a total of $1 Million in charitable funding for COVID-19 relief efforts to eligible organizations around the world.

Cohen Veterans Bioscience (CVB), the Center for Biomedical Research Transparency (CBMRT) and Mary Ann Liebert, Inc., publishers, in their continued efforts to advance the publication of research with negative findings, announced today the launch of Neurotrauma Reports Null Hypothesis at the 10th Annual Traumatic Brian Injury Conference

The U.S. Food and Drug Administration is now using LORENZ docuBridge and eValidator. The Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research, are both using the LORENZ solutions now to process incoming as well legacy submissions.